Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Doubleblind, Randomized Multicenter Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia

NCT00887276 is registered in ClinicalTrials.gov with University of Ulm as lead sponsor.

NCT NCT00887276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00887276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Doubleblind, Randomized Multicenter Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia
Lead sponsor
University of Ulm
Phase
Phase 4
Overall status
Terminated
Start date
November 30, 2008
Completion date
January 31, 2011
Enrollment
290 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

community acquired pneumonia